
|Articles|March 15, 2003
Lessons from ONTT help in management of optic neuritis
Baltimore-Ophthalmologists can now use new guidelines on how best to treat optic neuritis based on the results from the Optic Neuritis Treatment Trial (ONTT), which followed long-term outcomes for 10 years, according to Neil R. Miller, MD, who spoke at the Current Concepts in Ophthalmology Meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What if? Ophthalmology without OCT – Part 1
2
AAO 2025: Ophthalmic World Leaders honors 2025 leadership awardees
3
ICYMI: AAO 2025 showcases new technologies and continued research
4
Q&A: William F. Wiley, MD, on what BVI's trifocal IOL approval means for US premium vision options
5

















































.png)


